<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02043444</url>
  </required_header>
  <id_info>
    <org_study_id>12 555 01</org_study_id>
    <secondary_id>PHRC 2012</secondary_id>
    <nct_id>NCT02043444</nct_id>
  </id_info>
  <brief_title>Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT</brief_title>
  <acronym>AzoPredHisto</acronym>
  <official_title>Comparison of FDG PET-CT Estimated Testis Functional Value Between Patients Having Positive Testicular Sperm Cells Extraction and Patients With a Negative Extraction, in Men With Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare FDG PET-CT parameters between azoospermia patients having an extraction of sperm
      cells by positive testicular extraction and those with a negative extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One third of infertilities is of exclusive male origin and one third of mixed origin
      (presence of a male factor). Ten percent of infertile male have azoospermia with a secretory
      origin in most of cases. Surgical extraction of spermatozoa from testicle is the unique
      possibility to increase the chance for these men to have children using in vitro fecundation.
      However, surgical extraction of spermatozoa is successful in 50% of these patients. To date,
      none of the methods for exploration of male fertility (spermogram, hormonal investigation -
      with dosage of FSH (follicle stimulating hormone) and inhibin B - and scrotal ultrasound) can
      predict the success of surgical sperm cells extraction. We also miss the prognostic markers
      of the testicular function recovery after sterilizing treatments (chemotherapy,
      radiotherapy). The presence of GLUT3 (glucose) transporters, which are responsible for the
      fluoro deoxyglucose uptake, has been reported in seminiferous tubules. We have previously
      shown in a pilot study on a population of men without testis cancer that FDG PET-CT
      parameters - including the standardized uptake value mean, the standardized uptake value max,
      and the functional testicular volume - were correlated with the parameters of spermogram
      (sperm count, motility, vitality). These findings open the way to investigations on the role
      of the FDG PET-CT in evaluation of secretory azoospermia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measure of standardized uptake value (SUV)</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison between functional volume with PET exam and volume obtained by scrotal echography</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>comparison functional volume with FSH and inhibin</measure>
    <time_frame>1 month</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Fertility</condition>
  <arm_group>
    <arm_group_label>secretory azoospermia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>110 men with secretory azoospermia will have FDG PET-CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>excretory azoospermia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 men with secretory azoospermia will have FDG PET-CT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normospermia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 men with secretory azoospermia will have FDG PET-CT</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>FDG PET-CT</intervention_name>
    <arm_group_label>secretory azoospermia</arm_group_label>
    <arm_group_label>excretory azoospermia</arm_group_label>
    <arm_group_label>normospermia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        absence of sperm cells on 2 spermograms in 3 months interval testicular size has to be
        determined in order to categorized in a group to accept surgery-

        Exclusion Criteria:

        allergy to fluoro deoxyglucose clinical varicocele
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric HUYGHE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric HUYGHE, MD</last_name>
    <phone>0033561771041</phone>
    <email>huyghe.e@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thierry ALMONT, PhD</last_name>
    <phone>0033561771041</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UHBordeaux</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henri CLERMONT GALLERANDE, MD</last_name>
      <phone>0033556795540</phone>
      <email>henri.de-clermont-gallerande@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Henri CLERMONT GALLERANDE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Marc RIGOT, MD</last_name>
      <phone>0033320446793</phone>
      <email>jean.marc.rigot@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Marc RIGOT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre europ√©en Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas THIOUNN, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Louis SIBERT, MD</last_name>
      <phone>0033232888173</phone>
      <email>louis.sibert@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>Louis SIBERT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UHToulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric HUYGHE, MD</last_name>
      <phone>0033561771041</phone>
      <email>huyghe.e@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Patrice NJOMNANG, PhD</last_name>
      <phone>0033561771041</phone>
    </contact_backup>
    <investigator>
      <last_name>Eric HUYGHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ferretti L, Sargos P, Gross-Goupil M, Izard V, Wallerand H, Huyghe E, Rigot JM, Durand X, Benoit G, Ferriere JM, Droupy S. Testicular-sparing surgery for bilateral or monorchide testicular tumours: a multicenter study of long-term oncological and functional results. BJU Int. 2014 Dec;114(6):860-4. doi: 10.1111/bju.12549. Epub 2014 Aug 16.</citation>
    <PMID>24180380</PMID>
  </reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2013</study_first_submitted>
  <study_first_submitted_qc>January 21, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2014</study_first_posted>
  <last_update_submitted>November 24, 2017</last_update_submitted>
  <last_update_submitted_qc>November 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

